TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Benchmark Genetics Norway AS
Closing information (x1000 EUR)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover |
36,802
|
33,995
|
28,596 |
Financial expenses |
527
|
557
|
504 |
Earnings before taxes |
4,804
|
3,889
|
1,905 |
Total assets |
28,567
|
31,161
|
32,110 |
Current assets |
7,840
|
9,094
|
9,660 |
Current liabilities |
8,832
|
7,803
|
5,602 |
Equity capital |
13,869
|
10,903
|
8,050 |
- share capital |
799
|
860
|
883 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency |
48.5%
|
35.0%
|
25.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
13.1%
|
11.4%
|
6.7% |
Return on assets (ROA) |
18.7%
|
14.3%
|
7.5% |
Current ratio |
88.8%
|
116.5%
|
172.4% |
Return on equity (ROE) |
34.6%
|
35.7%
|
23.7% |
Change turnover |
5,215
|
6,151
|
5,141 |
Change turnover % |
17%
|
22%
![]() |
22% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.